Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in Healthy Participants
Recruiting now · Phase 1 · Has a placebo group
Conditions studied: Healthy
In brief
The primary objective of this study is to determine whether equivalent moderately high doses of LSD, psilocybin, and DMT produce qualitatively similar peak effects when the effect duration is standardized with ketanserin. A DMT infusion mimicking oral LSD and psilocybin administrations will be tested, as well as intravenously administered ketanserin.
Key facts
- Study ID
- NCT06899334
- Run by
- University Hospital, Basel, Switzerland
- People needed
- 24
- Starts
- 2025-04-01
- Expected to finish
- 2026-08-01
- Last updated by the study team
- 2025-03-27
Who can join
Age: 25 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Good understanding of the German language
- Understanding of procedures and risks associated with the study
- Willing to adhere to the protocol and signing of the consent form
- Willing to refrain from the consumption of illicit psychoactive substances during the study
- Willing not to operate heavy machinery within 48 h after administration of a study substance
- Willing to use effective birth control throughout study participation
- Body mass index 17 - 34.9 kg/m2
You may not qualify if…
- Relevant chronic or acute medical condition
- Current or previous major psychiatric disorder (e.g. psychotic disorder)
- Psychotic disorder or bipolar disorder in first-degree relatives
- Hypertension (SBP>140/90 mmHg) or hypotension (SBP<85 mmHg)
- Bradycardia (< 45 bpm)
- Prolonged QTc interval (males: >450 ms, females: >470 ms)
- AV block II° (Mobitz type and Webckebach type) and III°
- Hallucinogenic substance use (not including cannabis) more than 20 times or any time within the previous two months
- Pregnancy or current breastfeeding
- Participation in another clinical trial (currently or within the last 30 days)
- Use of medication that may interfere with the effects of the study medication
- Tobacco smoking (>10 cigarettes/day)
- Excessive consumption of alcoholic beverages (>15 drinks/week)
Where it is running
- University Hospital — Basel, Switzerland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.